Anmeldung erfolgt in Kürze...
Details werden geladen...
Tango Therapeutics Announces Executive Chair Transition | The Manila Times
BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Dr. Barbara Weber, the Executive Chairman of the Board of Directors of Tango Therapeutics, will be stepping down in connection with other pursuits.
Ähnliche Seiten
Tango Therapeutics Announces Proposed $500 Million Public Offering | The Manila Times
https://www.manilatimes.net/2026/06/09/tmt-newswire/globenewswire/tango-therapeutics-announces-proposed-500-million-public-offering/2361159
Tango Therapeutics Appoints Robert Azelby to Board of Directors | The Manila Times
https://www.manilatimes.net/2026/06/23/tmt-newswire/globenewswire/tango-therapeutics-appoints-robert-azelby-to-board-of-directors/2370466Spyre Therapeutics Announces Grants of Inducement Awards | The Manila Times
https://www.manilatimes.net/2026/08/08/tmt-newswire/globenewswire/spyre-therapeutics-announces-grants-of-inducement-awards/2401238Allogene Therapeutics Announces Planned CEO Succession | The Manila Times
https://www.manilatimes.net/2026/05/29/tmt-newswire/globenewswire/allogene-therapeutics-announces-planned-ceo-succession/2354208Spyre Therapeutics Announces Grants of Inducement Awards | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/spyre-therapeutics-announces-grants-of-inducement-awards/2359850